Eleni Antoniadou

G. Gennimatas General Hospital

Eth. Aminis 41

Thessaloniki, 54635

Greece

SCHOLARLY PAPERS

2

DOWNLOADS

928

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Immunogenicity after the First Dose of the BNT162b2 mRNA COVID-19 Vaccine: Real-World Evidence from Greek Healthcare Workers

Number of pages: 10 Posted: 19 Feb 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, G. Gennimatas General Hospital, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 777 (37,643)

Abstract:

Loading...

vaccine, BNT162b2, SARS-CoV-2, immunogenicity, healthcare workers, Greece, reactogenicity

2.

Second Dose of the BNT162b2 mRNA Vaccine in Greece: The Value of Timely Administration

Number of pages: 8 Posted: 01 Apr 2021
G. Gennimatas General Hospital, Aristotle University of Thessaloniki - Department of Clinical Pharmacology, University of Bern - University Institute of Clinical Chemistry, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital, G. Gennimatas General Hospital and Aristotle University of Thessaloniki - Department of Clinical Pharmacology
Downloads 151 (229,657)

Abstract:

Loading...

BNT162b2 mRNA vaccine, immunogenicity, seropositive, Greece